Marshall Wace North America’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-27,177
| Closed | -$711K | – | 1511 |
|
|
2020
Q4 | $711K | Sell |
27,177
-210,813
| -89% | -$5.52M | ﹤0.01% | 1016 |
|
|
2020
Q3 | $4.14M | Buy |
+237,990
| New | +$4.14M | 0.03% | 432 |
|
|
2020
Q2 | – | Sell |
-117,644
| Closed | -$1.4M | – | 1203 |
|
|
2020
Q1 | $1.4M | Buy |
117,644
+99,664
| +554% | +$1.18M | 0.01% | 555 |
|
|
2019
Q4 | $217K | Buy |
+17,980
| New | +$217K | ﹤0.01% | 957 |
|
|
2019
Q3 | – | Sell |
-81,348
| Closed | -$907K | – | 1341 |
|
|
2019
Q2 | $907K | Sell |
81,348
-47,787
| -37% | -$533K | 0.01% | 780 |
|
|
2019
Q1 | $1.52M | Sell |
129,135
-17,288
| -12% | -$203K | 0.01% | 580 |
|
|
2018
Q4 | $1.96M | Buy |
+146,423
| New | +$1.96M | 0.02% | 434 |
|
|
2018
Q3 | – | Sell |
-65,012
| Closed | -$1.02M | – | 985 |
|
|
2018
Q2 | $1.02M | Sell |
65,012
-256,252
| -80% | -$4.03M | 0.01% | 921 |
|
|
2018
Q1 | $5.29M | Buy |
+321,264
| New | +$5.29M | 0.03% | 556 |
|
|
2017
Q4 | – | Sell |
-466,460
| Closed | -$8.86M | – | 1402 |
|
|
2017
Q3 | $8.86M | Sell |
466,460
-695,370
| -60% | -$13.2M | 0.06% | 396 |
|
|
2017
Q2 | $13.9M | Buy |
+1,161,830
| New | +$13.9M | 0.1% | 247 |
|